Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1988 1
1989 2
1990 1
1991 1
1993 2
1994 1
1995 2
1996 5
1997 11
1998 13
1999 12
2000 14
2001 12
2002 5
2003 14
2004 12
2005 7
2006 6
2007 4
2008 9
2009 5
2010 11
2011 11
2012 11
2013 7
2014 9
2015 6
2016 5
2017 5
2018 6
2019 2
2020 3
2021 5
2022 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

207 results

Results by year

Filters applied: . Clear all
Page 1
Update on melatonin receptors: IUPHAR Review 20.
Jockers R, Delagrange P, Dubocovich ML, Markus RP, Renault N, Tosini G, Cecon E, Zlotos DP. Jockers R, et al. Among authors: delagrange p. Br J Pharmacol. 2016 Sep;173(18):2702-25. doi: 10.1111/bph.13536. Epub 2016 Aug 8. Br J Pharmacol. 2016. PMID: 27314810 Free PMC article. Review.
Physiological and metabolic functions of melatonin.
Barrenetxe J, Delagrange P, Martínez JA. Barrenetxe J, et al. Among authors: delagrange p. J Physiol Biochem. 2004 Mar;60(1):61-72. doi: 10.1007/BF03168221. J Physiol Biochem. 2004. PMID: 15352385 Review.
Therapeutic potential of melatonin ligands.
Delagrange P, Boutin JA. Delagrange P, et al. Chronobiol Int. 2006;23(1-2):413-8. doi: 10.1080/07420520500464387. Chronobiol Int. 2006. PMID: 16687314 Review.
Molecular tools to study melatonin pathways and actions.
Boutin JA, Audinot V, Ferry G, Delagrange P. Boutin JA, et al. Among authors: delagrange p. Trends Pharmacol Sci. 2005 Aug;26(8):412-9. doi: 10.1016/j.tips.2005.06.006. Trends Pharmacol Sci. 2005. PMID: 15992934 Review.
Therapeutic perspectives for melatonin agonists and antagonists.
Delagrange P, Atkinson J, Boutin JA, Casteilla L, Lesieur D, Misslin R, Pellissier S, Pénicaud L, Renard P. Delagrange P, et al. J Neuroendocrinol. 2003 Apr;15(4):442-8. doi: 10.1046/j.1365-2826.2003.01016.x. J Neuroendocrinol. 2003. PMID: 12622848 Review.
NRH:quinone reductase 2: an enzyme of surprises and mysteries.
Vella F, Ferry G, Delagrange P, Boutin JA. Vella F, et al. Among authors: delagrange p. Biochem Pharmacol. 2005 Dec 19;71(1-2):1-12. doi: 10.1016/j.bcp.2005.09.019. Epub 2005 Oct 25. Biochem Pharmacol. 2005. PMID: 16253210 Review.
207 results